Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?

Natural killer (NK) cells play a crucial role in early immunity after hematopoietic stem cell transplantation because they are the first lymphocyte subset recovering after the allograft. In this study, we analyzed the development of NK cells after intrabone umbilical cord blood (CB) transplantation in 18 adult patients with hematologic malignancies. Our data indicate that, also in this transplantation setting, NK cells are the first lymphoid population detectable in peripheral blood. However, different patterns of NK-cell development could be identified. Indeed, in a group of patients, a relevant fraction of NK cells expressed a mature phenotype characterized by the KIR(+)NKG2A(-) signature 3-6 months after transplantation. In other patients, most NK cells maintained an immature phenotype even after 12 months. A possible role for cytomegalovirus in the promotion of NK-cell development was suggested by the observation that a more rapid NK-cell maturation together with expansion of NKG2C(+) NK cells was confined to patients experiencing cytomegalovirus reactivation. In a fraction of these patients, an aberrant and hyporesponsive CD56(-)CD16(+)p75/AIRM1(-) NK-cell subset (mostly KIR(+)NKG2A(-)) reminiscent of that described in patients with viremic HIV was detected. Our data support the concept that cytomegalovirus infection may drive NK-cell development after umbilical CB transplantation.

[1]  P. J. Norris,et al.  Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection , 2011, Proceedings of the National Academy of Sciences.

[2]  S. Schnittger,et al.  Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. , 2011, Blood.

[3]  L. Ruggeri,et al.  Expansion of CD56-Negative, CD16-Positive, KIR-Expressing Natural Killer Cells after T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation , 2011, Acta Haematologica.

[4]  Charles C. Kim,et al.  NK Cells and Immune “Memory” , 2011, The Journal of Immunology.

[5]  H. Ljunggren,et al.  Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus , 2011, The Journal of experimental medicine.

[6]  M. Caligiuri,et al.  Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.

[7]  T. Strowig,et al.  Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. , 2010, Blood.

[8]  H. Pircher,et al.  CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. , 2010, Blood.

[9]  H. Ljunggren,et al.  Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. , 2010, Blood.

[10]  H. Ljunggren,et al.  CD56 negative NK cells: origin, function, and role in chronic viral disease. , 2010, Trends in immunology.

[11]  A. Thiel,et al.  CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. , 2010, Blood.

[12]  F. Locatelli,et al.  Cord blood transplantation in children with haematological malignancies. , 2010, Best practice & research. Clinical haematology.

[13]  J. Ritz,et al.  Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis. , 2010, Blood.

[14]  R. González-Amaro,et al.  Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children , 2010, European journal of immunology.

[15]  K. Malmberg,et al.  Tolerant and diverse natural killer cell repertoires in the absence of selection. , 2010, Experimental cell research.

[16]  M. Caligiuri,et al.  CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. , 2010, Blood.

[17]  A. Moretta,et al.  Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection , 2010, AIDS.

[18]  A. Moretta,et al.  The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. , 2009, Blood.

[19]  D. Bushnell,et al.  KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C , 2009, The Journal of experimental medicine.

[20]  M. Colonna,et al.  Hidden talents of natural killers: NK cells in innate and adaptive immunity , 2009, EMBO reports.

[21]  M. Verneris,et al.  The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells , 2009, British journal of haematology.

[22]  H. Ljunggren,et al.  KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. , 2009, Blood.

[23]  D. Lilleri,et al.  Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation. , 2009, The Journal of infectious diseases.

[24]  P. Debré,et al.  Fully functional NK cells after unrelated cord blood transplantation , 2009, Leukemia.

[25]  M. Sormani,et al.  Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation. , 2008, Blood.

[26]  Peter Parham,et al.  MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. , 2008, Blood.

[27]  M. Gobbi,et al.  Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. , 2008, The Lancet. Oncology.

[28]  T. Kuijpers,et al.  Human NK cells can control CMV infection in the absence of T cells. , 2008, Blood.

[29]  M. Robin,et al.  An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation1 , 2008, The Journal of Immunology.

[30]  J. Michaëlsson,et al.  Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. , 2008, Clinical immunology.

[31]  Y. Akatsuka,et al.  CD16+ CD56− NK cells in the peripheral blood of cord blood transplant recipients: a unique subset of NK cells possibly associated with graft‐versus‐leukemia effect , 2008, European journal of haematology.

[32]  V. Boussiotis,et al.  Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. , 2008, Clinical immunology.

[33]  A. Thiel,et al.  CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation1 , 2007, The Journal of Immunology.

[34]  M. Caligiuri,et al.  Human natural killer cell development , 2006, Immunological reviews.

[35]  B. Clotet,et al.  Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. , 2006, The Journal of infectious diseases.

[36]  A. Angulo,et al.  Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. , 2006, Blood.

[37]  P. Debré,et al.  NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. , 2005, Blood.

[38]  P. Parham MHC class I molecules and kirs in human history, health and survival , 2005, Nature Reviews Immunology.

[39]  A. Fauci,et al.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[40]  N. Malats,et al.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. , 2004, Blood.

[41]  M. Labopin,et al.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. , 2004, The New England journal of medicine.

[42]  F. Locatelli,et al.  Analysis of immune reconstitution in children undergoing cord blood transplantation. , 2001, Experimental hematology.

[43]  R. Biassoni,et al.  Identification and Molecular Cloning of P75/Airm1, a Novel Member of the Sialoadhesin Family That Functions as an Inhibitory Receptor in Human Natural Killer Cells , 1999, The Journal of experimental medicine.

[44]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[45]  J. Gaddy,et al.  Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. , 1997, Cellular immunology.

[46]  L. Moretta,et al.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.

[47]  G. Trinchieri,et al.  Human natural killer cells. , 1979, Transplantation proceedings.

[48]  M. Robin,et al.  An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. , 2008, Journal of immunology.

[49]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[50]  L. Lanier NK cell receptors. , 1998, Annual review of immunology.

[51]  R. Biassoni,et al.  Receptors for HLA class-I molecules in human natural killer cells. , 1996, Annual review of immunology.